Literature DB >> 12801743

Antiangiogenesis drug promising for metastatic colorectal cancer.

Michael McCarthy.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12801743     DOI: 10.1016/S0140-6736(03)13603-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  20 in total

Review 1.  A role for antiangiogenic therapy in breast cancer.

Authors:  Marsha A Moses; Jay Harper; Cecilia A Fernández
Journal:  Curr Oncol Rep       Date:  2004-01       Impact factor: 5.075

Review 2.  Therapeutic inhibition of angiogenesis.

Authors:  Hua-Tang Zhang; Roy Bicknell
Journal:  Mol Biotechnol       Date:  2003-10       Impact factor: 2.695

3.  Prognostic impact of intrahepatic lymphatic and microvascular involvement in cases of colorectal liver metastases.

Authors:  Maximilian Bockhorn; Georgios Sotiropoulos; Jan Neuhaus; George Sgourakis; Sien-Yi Sheu; Ernesto Molmenti; Christian Fingas; Tanja Trarbach; Andreja Frilling; Christoph E Broelsch
Journal:  Int J Colorectal Dis       Date:  2009-02-25       Impact factor: 2.571

4.  Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner.

Authors:  Takahiro Osawa; Noritaka Ohga; Yasuhiro Hida; Kazuko Kitayama; Kosuke Akiyama; Yuichiro Onodera; Manabu Fujie; Nobuo Shinohara; Masanobu Shindoh; Katsuya Nonomura; Kyoko Hida
Journal:  Cancer Sci       Date:  2012-04-17       Impact factor: 6.716

5.  Dovitinib (TKI258), a multi-target angiokinase inhibitor, is effective regardless of KRAS or BRAF mutation status in colorectal cancer.

Authors:  Choong-Kun Lee; Myung Eun Lee; Won Suk Lee; Jeong Min Kim; Kyu Hyun Park; Tae Soo Kim; Kang Young Lee; Joong Bae Ahn; Hyun Cheol Chung; Sun Young Rha
Journal:  Am J Cancer Res       Date:  2014-12-15       Impact factor: 6.166

6.  Two cases of bowel perforation associated with sunitinib treatment for renal cell carcinoma.

Authors:  Yoshinori Hoshino; Hirotoshi Hasegawa; Yoshiyuki Ishii; Takashi Endo; Hiroki Ochiai; Koji Okabayashi; Gou Kaneko; Shuji Mikami; Makio Mukai; Mototsugu Oya; Yuko Kitagawa
Journal:  Int J Clin Oncol       Date:  2011-09-17       Impact factor: 3.402

7.  Prognostic values of tumor endothelial markers in patients with colorectal cancer.

Authors:  K A Rmali; M C A Puntis; W G Jiang
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

8.  Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.

Authors:  Yu-Wen Zhang; Yanli Su; Olga V Volpert; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

9.  The effect of bevacizumab on human malignant melanoma cells with functional VEGF/VEGFR2 autocrine and intracrine signaling loops.

Authors:  Una Adamcic; Karolina Skowronski; Craig Peters; Jodi Morrison; Brenda L Coomber
Journal:  Neoplasia       Date:  2012-07       Impact factor: 5.715

10.  Effective inhibition of xenografts of hepatocellular carcinoma (HepG2) by rapamycin and bevacizumab in an intrahepatic model.

Authors:  Lai-Chun Ong; In-Chin Song; Yi Jin; Irene H C Kee; Eeyan Siew; Sidney Yu; Choon-Hua Thng; Hung Huynh; Pierce K H Chow
Journal:  Mol Imaging Biol       Date:  2009-03-28       Impact factor: 3.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.